NEW YORK (GenomeWeb) – MDxHealth today announced an agreement with preferred provider organization Galaxy Health Network to provide access to MDxHealth's ConfirmMDx for Prostate Cancer test.
Based in Arlington, Texas, Galaxy has a provider network of more than 400,000 physicians, 2,700 hospitals, and 47,000 ancillary providers, as well as more than 3.5 million covered lives. Today's agreement brings the total number of covered lives with access to ConfirmMDx to about 147 million in the US, MDxHealth said.
The epigenetic assay helps urologists distinguish true-negative biopsies from those at risk for occult cancer.
In December, MDxHealth added HealthSmart and Fortified Provider Network to its payor network.